Independent information resource
Clear guides, comparisons, research summaries, and question-led context for people looking into ibogaine and multiple sclerosis.
Honest answers, held carefully
What we offer
Mango Strata is an independent resource on ibogaine and multiple sclerosis. Our information services are built for people who want plain language without promotion: what is known, what is uncertain, and where serious safety questions remain. The broader ibogaine and MS overview provides the shared starting point for this work.
Ibogaine is a psychoactive substance associated with the iboga plant, but it is not an established treatment for MS. A basic description of the compound is available through Wikipedia’s ibogaine entry; our role is to add careful context rather than make treatment claims.
Information services
These are informational materials, not medical services. They are designed to help readers identify the questions worth asking before interpreting claims about ibogaine for MS.
Focused explainers separate proposed relevance from established evidence, including the difference between personal accounts and research. Our approach is grounded in the principles behind Mango Strata: scientific humility, safety first, plain language, evidence context, and independence.
Comparison pages help readers place ibogaine-related statements beside what is actually being asserted, what evidence would be needed, and what cannot be concluded. That context matters when reviewing claims about ibogaine therapy benefits.
Research summaries clarify study limits, terminology, and unanswered questions without presenting ibogaine as an MS intervention. Readers can also compare those boundaries with background on the psychedelic drug ibogaine and with the FDA’s warning about serious ibogaine risks.
Question-led materials organize concerns around evidence quality, regulation, screening claims, costs, and safety. They may help readers make sense of discussions about ibogaine treatment costs without turning information into a recommendation or a promise of outcome.
Context should travel with every claim.
A practical reading lens
Materials about documentaries, formulations, alcohol use, or location-based programs can be compelling while still leaving essential questions unanswered. Our guides encourage readers to distinguish a documentary account of ibogaine from clinical evidence, and to consider why claims related to ibogaine for extreme alcoholism do not automatically answer questions about MS.
Location and product language also deserve scrutiny. References to ibogaine centers in Mexico, ibogaine HCl information, or treatment centers in Canada are not evidence that a setting, product, or protocol is appropriate for a person with MS.
Questions answered
The point is not to steer a decision. It is to make uncertainty and safety concerns easier to see.
No. Mango Strata does not present ibogaine as an established MS treatment. Multiple sclerosis is a complex immune-mediated condition; the National Institute of Neurological Disorders and Stroke overview of MS describes the condition and its effects. Claims about ibogaine should not be substituted for medical assessment or evidence-based care.
Because safety risks are serious, including potential cardiac risks, and they cannot be inferred away by a promising story or a claimed benefit. Information about a setting is not a substitute for individualized medical or legal advice.
They can help you identify unsupported leaps, understand research limits, and prepare better questions when encountering ibogaine-related claims. They cannot determine whether ibogaine is safe, suitable, or effective for any individual.
Keep the context close
Use Mango Strata’s evidence-first materials to approach ibogaine for MS with care, clarity, and attention to what remains unknown.